From 20 September to 3 October, 2024, CACLP held a series of five successful online promotional webinars, aimed at fostering international collaboration within the in vitro diagnostics (IVD) industry.

With the improvement of Chinese manufacturing industry's contribution to the global economy in recent years, more and more international brands, such as Roche, Abbott, Siemens, Beckman, tend to establish the production bases and carry out production in China, to achieve the localization of imported brands. The four giants "Roche, Abbott, Siemens, Beckman" started the localization layout as early as 1985 in China.

Published by Springer-Verlag, In Vitro Diagnostic Industry in China is a specialized English monograph that fills a gap and provides a detailed introduction to the history, current status, outstanding companies and products of China's IVD industry.

To enhance the overall experience for both our exhibitors and visitors, the China IVD Supply Chain Expo in March 2024 will be divided into five specialized zones for Supply Chain, Consumables, General Lab Equipments, Components, and Raw Materials in addition to the CACLP show, which shall mainly present the Instruments and Reagents as well as International Pavilion.

Through MDUFA V, the FDA committed to several international harmonization initiatives and secured additional resources to support the work. The publication of a draft strategic plan was the first item on the MDUFA V convergence and reliance agenda.

With over 40 years of development, China's in vitro diagnostic (IVD) industry has made significant strides, presenting a comprehensive range of products that boast improving quality and surging export demands. The internationalization of IVD products, especially concerning human health, emerges as a pivotal strategy of companies for manufacturing, development, and future growth.

The February operating data of the three major airlines, China Eastern Airlines (MU), China Southern Airlines (CZ) & Air China (CA) were released.